Jun 13 (Prensa Latina) A Dominican specialist has described as amazingly good the results of Cuban medicine Heberprot-P in the first stage of its application in this Caribbean country.

Director General of the Center for Genetic Engineering and Biotechnology Luis Herrera and Director General of the National Institute of Angiology Héctor Alvarez presented Heberprot-P before specialists in this country.

Doctor Nalini Campillo set out the results of several cases treated with Heberprot-P which could benefit about a million Dominicans with diabetes, a disease that affects children and adults.

Doctor Alvarez explained in details the medical procedure applied in the treatment of diabetic foot in patients with diabetes to help the integral care Heberprot-P is distributed in the Dominican Republic by Caribbean Drug Company which collaborates with Cuba in the field of health.